Under the skin of innovationLEO’s Innovation Lab is working at arm’s length from the main company to encourage original thinking and develop Share XUnder the skin of innovationhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/leo-innovation-lab-john-zibert-digital/
Embracing next generation patient centricityPharma has largely accepted the value and importance of patient centricity – now it’s time to scale it Share XEmbracing next generation patient centricityhttps://pharmaphorum.com/patients/embracing-next-generation-patient-centricity/
Eyeforpharma 2019: Dan SpacieSyneos Health’s Health Trend Ten report says that commercial models will see radical reorganisation in the coming years. Share XEyeforpharma 2019: Dan Spaciehttps://pharmaphorum.com/views-analysis-sales-marketing/eyeforpharma-2019-dan-spacie/
Harnessing RWE in rare diseasesAhead of eyeforpharma Philadelphia 2019, Sonal Bhatia, Pfizer’s vice president, North America medical lead, rare disease talked to Share XHarnessing RWE in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/harnessing-rwe-in-rare-diseases/
The unmet needs of bleeding disorder patientsAhead of eyeforpharma Philadelphia 2019, we talk to speaker and haemophilia advocate Michelle Rice about the changing landscape Share XThe unmet needs of bleeding disorder patientshttps://pharmaphorum.com/views-analysis-patients/the-unmet-needs-of-bleeding-disorder-patients/
Eyeforpharma Barcelona 2019 roundupThis year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting Share XEyeforpharma Barcelona 2019 rounduphttps://pharmaphorum.com/digital/eyeforpharma-barcelona-2019-roundup/
eyeforpharma barcelona day twoDay two: Wednesday 13 March Highlights include: John Zibert, chief medical officer of LEO Innovation Lab, on being Share Xeyeforpharma barcelona day twohttps://pharmaphorum.com/views-and-analysis/eyeforpharma-barcelona-day-two/
eyeforpharma Barcelona day oneDay one: Tuesday 12 March Highlights include: Brent Saunders, CEO of Allergan, discusses the biggest challenges for the Share Xeyeforpharma Barcelona day onehttps://pharmaphorum.com/event-coverage/eyeforpharma-barcelona-2019-day-1/
The future of patient valueAhead of the 2019 eyeforpharma Barcelona conference, we asked speaker and awards judge Heather Moses – head of Share XThe future of patient valuehttps://pharmaphorum.com/views-analysis-patients/the-future-of-patient-value/
